Malix Tablets 2.5mg
Artw#rK • • Creative CesianB |
Artwork No. |
131011/19 |
Colours Used | |||
Customer |
Ennogen |
■ |
Black | |||
Description |
Glibenclamide Leaflet |
■ |
Keyline | |||
Market |
UK | |||||
Language |
English | |||||
Size |
160 x 270 mm | |||||
Min. Font Size |
9 pt | |||||
Page No. |
1 of 2 | |||||
e-mail : artworkcd@yahoo.com Ph : +91-09845609386 |
Version No. |
12 | ||||
Date |
19-03-14 | |||||
Softwa re |
Coreldraw 1 2 | |||||
Packaging Development |
Quality Assurance (QA) |
Quality Control (QC) |
Production | |||
![](/data/mhra/doc/97e231e6d2ac1277e0b10c4c7f67d84c_files/97e231e6d2ac1277e0b10c4c7f67d84c-1.jpg)
![](/data/mhra/doc/97e231e6d2ac1277e0b10c4c7f67d84c_files/97e231e6d2ac1277e0b10c4c7f67d84c-2.jpg)
PACKAGE LEAFLET: INFORMATION FORTHE USER
Read all of this leaflet carefully before you start taking this
medicine because it contains important information for
you.
• Keep this leaflet. You may need to read it again
• If you have any further questions, ask your doctor or pharmacist or nurse
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours
• If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Glibenclamide Tablets are and what they are used for
2. What you need to know before you take Glibenclamide Tablets
3. HowtotakeGlibenclamideTablets
4. Possible side effects
5. How to store Glibenclamide Tablets
6. Contents of the pack and other information
Glibenclamide belongs to a group of therapeutic medicines called sulphonylureas which are used for lowering your blood sugar. Glibenclamide Tablets are used for treatment of patients with Type II maturity onset and non-insulin dependent diabetes that do not respond adequately to diet changes alone.
Do not take Glibenclamide Tablets if you:
• Are hypersensitive (allergic) to glibenclamide or any of the other ingredients of Glibenclamide Tablets (listed in section 6)
• Havetype 1/juvenile diabetes or your diabetes is not stabilised
• Have diabetes and have had ketosis or have experienced diabetic coma
• Have thyroid problems
• Have kidney problems or liver disease
• Have functional problems with your adrenal glands
• Are pregnant, after delivery of your baby glibenclamide therapy may be started or resumed
• Have a blood condition called porphyria
• Are breastfeeding
• Are currently being treated with the medicine bosentan
• Have insulin dependant diabetes.
You should talk to your doctor before taking this medicine if you
are going to have an operation, if you have a serious accident
or severe infection, which can affect your diabetes.
Warnings and precautions
Talk to your doctor or pharmacist before taking Glibenclamide
Tablets if you:
• Start to have symptoms of jaundice such as yellowing of the eyes and skin. Your doctor may stop your medication
• Are elderly, seriously ill or malnourished as taking this medicine may lower your blood sugar too much.
Other medicines and Glibenclamide Tablets
Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed.
In particular tell your doctor if you are taking a medicine called bosentan which is used to treat high blood pressure.
These medicines may increase the effect that glibenclamide has on lowering your blood sugar:
• Anabolic steroids e.g nandrolone
• Medicines used to treat heart conditions such as ACE inhibitors or beta-blockers e.g captopril, atenolol
• Analgesics used to treat pain e.g aspirin, paracetamol and other Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen
• Anticoagulants to reduce blood clotting e.g warfarin and coumarin derivatives
• Antibacterials or antifungals e.g fluconazole, miconazole, sulphonamides, chloramphenicol
• Cimetidine used to treat ulcers
• Sulphinpyrazoneusedtotreatgout
• Monoamine-oxidase inhibitors used to treat depression
• Medicines used to treat arthritis e.g cyclophosphamide, phenylbutazone
• Medicines used to treat tuberculosis.
These medicines may decrease the hypoglycaemic effect of glibenclamide:-
• Diuretics e.g thiazide diuretics, furosemide, ethacrynic acid
• Phenothiazines used to treat schizophrenia
• Oral contraceptives containing oestrogen
• Corticosteroids
• Rifampicin, an antibiotic used to treat infections
• Ciclosporin, a medicine used after organ transplants.
These medicines may lower the body's tolerance to glucose:
• Calcium blockers used to treat heart conditions
• Lithium used to treat depression.
Pregnancy and breastfeeding
Ask your doctor or pharmacist for advice if you are pregnant or planning on becoming pregnant before taking this medicine. Consult your doctor if you are breast feeding or plan to breastfeed as small amounts of this medicine may pass into the mother's milk.
Driving and using machines
This medicine may make you feel dizzy, shaky, confused, weak and sleepy. These are some of the signs of low blood sugar. If you experience any of these then you should not drive or operate machinery.
Taking Glibenclamide Tablets with food and drink
Drinking alcohol while taking this medicine may affect the way that it works. Talk to your doctor if you want to drink alcohol while taking this medicine.
Glibenclamide Tablets contains lactose
This medicine contains lactose (a type of sugar), if you have been told by your doctor that you have an intolerance to some sugars talk to your doctor about taking this medicine.
Artw#rK • • Creative CesianB |
Artwork No. |
131011/19 |
Colours Used | |||
Customer |
Ennogen |
■ |
Black | |||
Description |
Glibenclamide Leaflet |
■ |
Keyline | |||
Market |
UK | |||||
Language |
English | |||||
Size |
160 x 270 mm | |||||
Min. Font Size |
9 pt | |||||
Page No. |
2 of 2 | |||||
e-mail : artworkcd@yahoo.com Ph : +91-09845609386 |
Version No. |
12 | ||||
Date |
19-03-14 | |||||
Softwa re |
Coreldraw 1 2 | |||||
Packaging Development |
Quality Assurance (QA) |
Quality Control (QC) |
Production | |||
Always take Glibenclamide Tablets exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure.
Taking this medicine
• Take this medicine by mouth
• Take with or immediately after food.
The usual dose for:
New diabetics: Patients should be started with 5mg daily or 2.5mg with elderly or ill patients. The doses may be increased by 2.5mg at intervals of one week as directed by your doctor. The maximum daily dose is 15mg.
Patients changing from other sulphonvlureas: the transfer can usually be carried outwithout a break in treatment. Initial treatment with glibenclamide is 5mg daily. If necessary this can be increased in steps of 2.5mg or 5mg. A dose of 5mg glibenclamide is equivalent to 1,000mg tolbutamide, 250mg chlorpropamide, 25mg glibornuride and 5mg glipizide.
Patients changing from biauanides: Glibenclamide treatment should be started with 2.5mg of glibenclamide and biguanide withdrawn. The dosage should then be adjusted by increments of 2.5mg to achieve control.
Children: Glibenclamide Tablets are unsuitable for children.
Ifyou take more Glibenclamide Tablets than you should
This medicine is to be taken at regular intervals, as determined by the physician. If you take too many tablets by mistake contact your nearest hospital casualty department or tell your doctor immediately. Take your tablet pack with you.
Low blood sugar (hypoglycaemia) may be treated in the conscious patient by administration of glucose or3or4 lumps of table sugar in water. If the patient is comatose, glucose can be administered as an intravenous infusion.
Ifyou stop taking Glibenclamide Tablets
Keep taking your tablets until your doctor tells you to stop. Do not stop taking your tablets just because you feel better. If you stop taking this medicine your symptoms may come back.
Ifyou forgetto take Glibenclamide Tablets
Ifyou have forgotten to take a dose, leave out that dose completely. Take your next dose at the normal time. Ifyou have trouble remembering to take the tablets, tell your doctor or pharmacist.
• There have been rare reports of changes to the blood including thrombocytopenia, agranulocytosis and anaemia. Ifyou notice that you have started to bruise more easily, you have bleeding gums or you bleed for a long time after injury and you feel very tired and are pale, you should contactyourdoctorAS SOON AS POSSIBLE. Ifyou become more susceptible to infections and develop mouth and throat ulcers, you should contact your doctor straight away.
![](/data/mhra/doc/97e231e6d2ac1277e0b10c4c7f67d84c_files/97e231e6d2ac1277e0b10c4c7f67d84c-3.jpg)
Other side effects:
• There have been reports of skin rashes whilst taking Glibenclamide Tablets. This includes itchy skin and being more prone to sunlight
• Low blood sugar levels (dizziness, confusion, shaking, increased sweating, sleepiness, feeling weak) in patients whose diet has not been adequately considered may occur
• Low blood sugar (hypoglycaemia) is more likely to occur in elderly or unwell/weak patients
• Stomach problems such as feeling sick (nausea), being sick (vomiting), stomach pain, diarrhoea, heartburn, loss of appetite, metallic taste in the mouth and a feeling of fullness have also been reported whilst taking Glibenclamide Tablets
• Temporary changes in sight have also been reported
• A rise in the sodium levels in the blood may occur. This will be seen in a blood test
• An increased appetite and weight gain have also been seen with these tablets.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Check the expiry date printed on the label or side of the box. Do not use after the expiry date stated on the label.
Do not store above 25°C. Store in the original package.
In case of any visible signs of deterioration, you should discard the package.
Medicines should not be disposed ofvia waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures help to protect the environment.
Keep out of the sight and reach of children
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Ifyou experience any ofthe following then STOP taking the medicine and contact a doctor Immediately
• Allergic reactions may occur rarely, with symptoms such as rash, itching, swelling of the face, wheeziness, shortness of breath, tightness in the chest, fever, low blood pressure and feeling dizzy particularly when standing up
• Allergic skin rashes may also occur such as erythema multiforme (red bulls eye/target lesions with dark centre surrounded by pale pink ring and bright red outer ring, which may appear on the palms or soles of the feet). Stevens-Johnson syndrome (rash with flushing, fever, blisters or ulcers), toxic epidermal necrolysis (reddening, peeling and swelling that resembles burns), exfoliative dermatitis (peeling of the skin over large areas of the body) and erythema nodosum (red lumps underneath the skin surface)
• Liver damage or jaundice may occur with symptoms such as yellowing of the skin or the whites of the eyes
What Glibenclamide Tablets contain:
Glibenclamide Tablets contain the active substance glibenclamide.
The other ingredients are: lactose, maize starch, gelatin, sodium carboxymethylcellulose, talc and magnesium stearate.
What Glibenclamide Tablets look like and contents of the pack
Glibenclamide Tablets 2.5mg have G1 on one side and a breakline on the other side.
Glibenclamide Tablets 5mg have G2 on one side and plain on the other side.
The tablets are packsizes of28, 30, 56, 60,84,90,100,112, 120, 250, 500 and 1000.
Marketing Authorisation Holder
Ennogen Pharma Limited
Unit G4, Riverside Industrial Estate,
Riverside Way, Dartford, DA1 5BS, UK.
This leafletwas last revised in March 2014.
SIZE :160X 270 (mm) Back